Front Range Biosciences Growth, Revenue, Number of Employees and Funding

Overview

Location:
Lafayette, CO USA
Total Funding:N/A
Industry:Biotech
Founded:2015
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Front Range Biosciences's estimated revenue is currently $7.3M per year.
  • Front Range Biosciences's estimated revenue per employee is $145700

Employee Data

  • Front Range Biosciences has 50 Employees.
  • Front Range Biosciences grew their employee count by 67% last year.
  • Front Range Biosciences currently has 1 job openings.

What Is Front Range Biosciences?

Plant growers are hamstrung by three major problems: expense, risk and safety, and a lack of innovation. The scientific tools of modern agriculture developed in the last 40 years have increased the profit, safety, and rate of innovation for the crops consumed daily worldwide. These tools include tissue culturing, genetic assays, and marker assisted breeding. Front Range Biosciences enables a grower to reduce crop loss due to pathogens, quickly sex a plant, and develop new strains of plants that have the most valuable commercial properties. We increase a grower's profit, reduce its risk, and give it new products. We have the right team of PhD bioscientists, MIT MBAs, DuPont plant experts, and seasoned biotechnology entrepreneurs. We have the right market, little professional competition, and the right product-market fit. Front Range Biosciences is a vertically integrated biotech company with a strong IP portfolio and licensing strategy. We are excited to usher a new era in modern plant breeding and growing.

keywords:N/A

50

Number of Employees

$7.3M

Revenue (est)

1

Current Jobs

67%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
MBio Diagnostic...
$5.1M3535%N/A
Mile High Labs
$26.2M181596%N/A
GlobeImmune
$5.1M350%N/A
Isolate Extract...
$6.4M4433%N/A
Front Range Bio...
$7.3M5067%N/A
Inscripta
$15.8M10954%N/A
ArcherDX
$33.3M23064%N/A
Clovis Oncology
$95.4M54011%N/A
miRagen Therape...
$3.9M8619%N/A
Biodesix
$19.1M15619%N/A